WIPO and the Medicines Patent Pool jointly host the presentation of the study: “Voluntary Licensing: Right for Health, Smart for Business”

WIPO and the Medicines Patent Pool (MPP) jointly organised the presentation of a new study, that demonstrates how voluntary licensing can advance access to medical technologies, while being commercially viable for biopharmaceutical companies. The study, conducted by the Boston Consulting Group (BCG), presents evidence that voluntary licensing is an effective mechanism to address global health disparities, especially in low- and middle-income countries (LMICs). Using both qualitative and quantitative analyses, the study illustrates how voluntary licensing advances access to medical products across multiple geographies while offering economic benefits for biopharmaceutical companies.

The study provides solid evidence that voluntary licensing can increase revenues for both innovator and generic companies, enhance access and encourage employee retention, leading to significant cost savings, with minimum costs and risks to companies.The study also demonstrates the advantages of voluntary licensing as a mechanism to support global partnerships, local manufacturing, and equitable access to healthcare solutions.

Access the report

Watch the recording of the presentation and discussions

View the recording

Agenda

Welcome

Amy Dietterich
Director of the Global Challenges Division  WIPO

Introductory remarks

Antony Taubman
Director Intellectual Property Division, WTO

Presentation:  Right for health, smart for business – highlights from the value report.

Sandra Nobre
Business Development, Executive Leadership Team Medicines Patent Pool

Roundtable discussion moderators

Meghmala Das
Business Development Alliance Manager, MPP

Siddhartha Prakash
Head, Global Health, WIPO

Roundtable discussion

James Anderson
Director Global Health, IFPMA

Dr Susana Almeida
Secretary General, IGBA

Takanori Sato
Chair, Global Health Sub-Committee, JPMA

Lizzie Wilson
Senior IP Attache, UK Mission to the UN and WTO

Dr Cary Adams
CEO UICC

Marumo Nkomo
Deputy Permanent Representative, South African Mission to WTO

Questions & Answers

From the floor and online